Implications of B10-like cell expansion in a model of impaired receptor editing
B10 样细胞扩增对受体编辑受损模型的影响
基本信息
- 批准号:9244625
- 负责人:
- 金额:$ 21.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-12-08 至 2018-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcetatesAdoptive TransferAnimalsAntibodiesAntibody FormationAntibody-Producing CellsAntigensAreaAutoantibodiesAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityB cell repertoireB-Cell DevelopmentB-Lymphocyte SubsetsB-LymphocytesBindingBone MarrowCell CommunicationCellsChronic Lymphocytic LeukemiaClinicalCompetenceComplicationCoupledDataDefectDiseaseEtiologyExhibitsFailureFeedbackFrequenciesGenesHumoral ImmunitiesImmune systemImmunoglobulin MImmunoglobulinsImmunophenotypingImmunosuppressionImmunosuppressive AgentsImpairmentIn VitroIncidenceInflammatory ResponseInterleukin-10IonomycinLeadLecithinLightLipopolysaccharidesLymphocytosisMediatingMembraneModelingMusMutationOutcomePathogenicityPatientsPatternPhenotypePlasma CellsPlayPopulationProductionPropertyReceptors, Antigen, B-CellRegulatory PathwayReportingRoleSiteSjogren&aposs SyndromeSpecificityStimulusT-LymphocyteTestingTransgenesTransgenic MiceWorkautoreactive B cellautoreactive T cellautoreactivitybasecytokinecytopeniaexperimental studyinsightinterleukin-21novelphorbol-12-myristatepreventreceptorresponse
项目摘要
PROJECT SUMMARY/ABSTRACT
Although B cells are best known for providing humoral immunity through the production of antigen-specific
antibodies, accumulating evidence suggests some B cell subsets can function to negatively regulate
inflammatory responses by producing the immunosuppressive cytokine IL10. Perhaps the best characterized
of these subsets is the B10 B cell, which is distinctive for its CD5+CD1dhiCD19hi phenotype and ability to
secrete IL10 in response to mitogenic stimuli. B10 B cells are thought to promote antigen-specific suppression
of autoreactive T cells through an IL10 (B cell) – IL21 (T cell) feedback loop established by cognate B cell-T
cell interactions. Interestingly, some CD5+ B cell populations have a propensity to react with membrane-
associated self-antigens and may also produce IL10 like B10 B cells. Furthermore, certain diseases
associated with expanded CD5+ B cells, such as chronic lymphocytic leukemia and Sjögren’s syndrome, show
an increased incidence of autoimmune cytopenias that occur when antibodies attack the host’s own cells.
Together, these data raise the possibility that the IL10-dependent feedback mechanism may function in
reverse to help constrain B cells reactive to membrane antigens, and that breakdown of this regulatory loop
may cause B cell-intrinsic autoimmune manifestations. We previously generated transgenic mice (called
dnRAG1 mice) which exhibit a receptor editing defect used to alter B cell receptor specificity away from self-
reactivity. These animals show an expanded CD5+ B cell population and impaired antibody production. We
have found that dnRAG1 CD5+ B cells share the immunophenotype and IL10-competence of B10 B cells,
leading us to hypothesize that a failure to successfully edit B cell receptor specificity against certain self-
antigens may cause the B cell to acquire B10-like properties to suppress B cell-intrinsic autoimmunity.
Consistent with this hypothesis, we show here that IL10-deficiency in dnRAG1 mice leads to elevated IgM
production. This hypothesis will be further tested by analyzing wild-type and dnRAG1 mice on IL10+/+ and
IL10-/- backgrounds to compare spontaneous and stimulation-induced antibody levels, autoantigen reactivity
profiles, immunoglobulin variable gene usage patterns, and the frequency of IgM antibody-producing cells. We
will also determine whether adoptively transferring CD5+ B cells from IL10+/+ dnRAG1 mice into IL10-/- dnRAG1
mice can restore immune suppression in these animals. Furthermore, we will test whether impaired receptor
editing in mice expressing a site-directed phosphatidylcholine (PtC)-specific heavy chain transgene enhances
CD5+ B cell accumulation and IL10-competence, and suppresses total or PtC-specific IgM production. The
results obtained from this study may reveal an important new mechanism for how B cell-intrinsic autoimmunity
against certain self-antigens are suppressed, and will identify autoantigens that may be subjected to tolerance
induction by receptor editing. This work may also suggest an etiology for certain autoimmune manifestations,
like cytopenias, that can arise as a clinical complication in diseases associated with expanded CD5+ B cells.
项目摘要/摘要
尽管B细胞以通过产生抗原特异性提供体液免疫而闻名
抗体,积累的证据表明,某些B细胞子集可以负调节
通过产生免疫抑制细胞因子IL10来产生炎症反应。也许是最好的特征
这些子集的是B10 B细胞,它的CD5+CD1DHICD19HI表型和能力与众不同。
秘密IL10响应有丝分裂刺激。 B10 B细胞被认为促进抗原特异性抑制
通过IL10(B细胞) - IL21(T细胞)反馈回路,由Cognate B Cell-T建立
细胞相互作用。有趣的是,某些CD5+ B细胞群体有望与膜反应
相关的自我抗原,也可能产生IL10,例如B10 B细胞。此外,某些疾病
与扩展的CD5+ B细胞相关,例如慢性淋巴细胞性白血病和Sjögren综合征
当抗体攻击宿主自己的细胞时,会增加自身免疫性细胞质的事件。
这些数据一起增加了IL10依赖性反馈机制的可能性
反向以帮助约束B细胞反应对膜抗原的反应,并破坏该调节环
可能导致B细胞中性自身免疫性表现。我们以前产生了转基因小鼠(称为
DNRAG1小鼠),其表现出用于改变自我自我的B细胞受体特异性的受体编辑缺陷
反应性。这些动物显示出扩展的CD5+ B细胞群体和抗体产生受损。我们
已经发现DNRAG1 CD5+ B细胞具有B10 B细胞的免疫表型和IL10能力,
导致我们假设未能成功编辑B细胞受体特异性针对某些自我
抗原可能导致B细胞获得类似B10的特性,以抑制B细胞中的自身免疫。
与这一假设一致,我们在这里表明DNRAG1小鼠的IL10缺陷导致IgM升高
生产。该假设将通过在IL10+/+和
IL10 - / - 背景比较赞助和刺激诱导的抗体水平,自身抗原反应性
特征,免疫球蛋白可变基因使用模式以及IgM抗体产生细胞的频率。我们
还将确定是否适当地将IL10+/+ DNRAG1小鼠中的CD5+ B细胞转移到IL10 - / - DNRAG1中
小鼠可以恢复这些动物的免疫抑制。此外,我们将测试接收器是否受损
表达位置定向磷脂酰胆碱(PTC)特异性重链转化的小鼠的编辑增强
CD5+ B细胞的积累和IL10能力,并抑制总或PTC特异性IgM产生。这
从这项研究中获得的结果可能揭示了B细胞中性自身免疫的重要新机制
针对某些自我抗原被抑制,并将识别可能受到耐受性的自动抗原
通过受体编辑诱导。这项工作还可能暗示某些自身免疫性表现的病因,
像细胞质一样,这可能是与扩展的CD5+ B细胞相关的疾病的临床并发症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patrick C. Swanson其他文献
Patrick C. Swanson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patrick C. Swanson', 18)}}的其他基金
Role of RACK1 in RAG1 degradation and B cell development
RACK1 在 RAG1 降解和 B 细胞发育中的作用
- 批准号:
10430247 - 财政年份:2021
- 资助金额:
$ 21.83万 - 项目类别:
Role of RACK1 in RAG1 degradation and B cell development
RACK1 在 RAG1 降解和 B 细胞发育中的作用
- 批准号:
10302865 - 财政年份:2021
- 资助金额:
$ 21.83万 - 项目类别:
DCAF1(VprBP) regulates FoxO1 to promote Rag transcription
DCAF1(VprBP)调控FoxO1促进Rag转录
- 批准号:
9808408 - 财政年份:2019
- 资助金额:
$ 21.83万 - 项目类别:
Role of VprBP in B cell development and V(D)J recombination
VprBP 在 B 细胞发育和 V(D)J 重组中的作用
- 批准号:
8876720 - 财政年份:2012
- 资助金额:
$ 21.83万 - 项目类别:
Role of VprBP in B cell development and V(D)J recombination
VprBP 在 B 细胞发育和 V(D)J 重组中的作用
- 批准号:
8499380 - 财政年份:2012
- 资助金额:
$ 21.83万 - 项目类别:
Role of VprBP in B cell development and V(D)J recombination
VprBP 在 B 细胞发育和 V(D)J 重组中的作用
- 批准号:
8688270 - 财政年份:2012
- 资助金额:
$ 21.83万 - 项目类别:
Role of VprBP in B cell development and V(D)J recombination
VprBP 在 B 细胞发育和 V(D)J 重组中的作用
- 批准号:
8345107 - 财政年份:2012
- 资助金额:
$ 21.83万 - 项目类别:
Defining the role of a novel E3 ubiquitin ligase in V(D)J recombination
定义新型 E3 泛素连接酶在 V(D)J 重组中的作用
- 批准号:
8313160 - 财政年份:2011
- 资助金额:
$ 21.83万 - 项目类别:
相似海外基金
Ovarian cancer using novel nanoparticle formulations
使用新型纳米颗粒制剂治疗卵巢癌
- 批准号:
8903749 - 财政年份:2014
- 资助金额:
$ 21.83万 - 项目类别: